Trademark: 98377992
Word
MM
Status Date
Tuesday, October 1, 2024
Filing Date
Friday, January 26, 2024
Published for Opposition
Tuesday, October 1, 2024
5 Antibody drug conjugate being medicines which deliver chemotherapy agents to kill cancer cells and/or abort cell multiplication; Tumor suppressing agents; Pharmaceutical preparations for suppressing tumors
44 Antibody testing for medical diagnostic or treatment purposes
The mark consists of mirroring "MM" design within circular carrier element.
Color is not claimed as a feature of the mark.
Jan 30, 2024
New Application Entered
Aug 22, 2024
Assigned To Examiner
Aug 23, 2024
Approved For Pub - Principal Register
Sep 11, 2024
Notification Of Notice Of Publication E-Mailed
Oct 1, 2024
Published For Opposition
Oct 1, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 13, 2024
Notice Of Design Search Code E-Mailed
Feb 12, 2024
New Application Office Supplied Data Entered
Trademark Alertz updated from USPTO on 2030-01-24